{"count": 2, "results": [{"_id": "33604594", "pmid": 33604594, "title": "Metformin use and the Risk of Gastrointestinal Malignancies in Diabetic Populations: A Meta-Analysis.", "journal": "Int J Clin Endocrinol Metab", "authors": ["Hevroni G", "Skwiersky S", "Zhyvotovska A", "McFarlane SI"], "date": "2020-01-01T00:00:00Z", "doi": "10.17352/ijcem.000052", "meta_date_publication": "2020", "meta_volume": "6", "meta_issue": "1", "meta_pages": "035-41", "score": 50250.75, "text_hl": "CONCLUSION: Our findings suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could be a useful neoadjuvant agent for @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@CRC cancer@@@ and as a possible preventive therapy for other @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ conditions related to @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@colorectal pathologies@@@ such as @<m>DISEASE_Adenomatous_Polyps</m> @DISEASE_MESH:D018256 @@@adenomatous polyps@@@ and @DISEASE_Inflammatory_Bowel_Diseases @DISEASE_MESH:D015212 @@@inflammatory bowel disease@@@. ", "citations": {"NLM": "Hevroni G, Skwiersky S, Zhyvotovska A, McFarlane SI. Metformin use and the Risk of Gastrointestinal Malignancies in Diabetic Populations: A Meta-Analysis. Int J Clin Endocrinol Metab. 2020;6(1):035-41. PMID: 33604594", "BibTeX": "@article{33604594, title={Metformin use and the Risk of Gastrointestinal Malignancies in Diabetic Populations: A Meta-Analysis.}, author={Hevroni G and Skwiersky S and Zhyvotovska A and McFarlane SI}, journal={Int J Clin Endocrinol Metab}, volume={6}, number={1}, pages={035-41}}"}}, {"_id": "22789400", "pmid": 22789400, "title": "Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer.", "journal": "Dig Liver Dis", "authors": ["Lee JH", "Jeon SM", "Hong SP", "Cheon JH", "Kim TI", "Kim WH"], "date": "2012-12-01T00:00:00Z", "doi": "10.1016/j.dld.2012.06.007", "meta_date_publication": "2012 Dec", "meta_volume": "44", "meta_issue": "12", "meta_pages": "1042-7", "score": 50049.586, "text_hl": "RESULTS: After a median follow-up of 58 months, a total of 33 @SPECIES_9606 @@@patients@@@ (28.9%) exhibited @<m>DISEASE_Adenomatous_Polyps</m> @DISEASE_MESH:D018256 @@@adenomatous colorectal polyps@@@ among the 114 @SPECIES_9606 @@@patients@@@ who used @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, compared with 58 (46.0%) @SPECIES_9606 @@@patients@@@ with @DISEASE_Adenoma @DISEASE_MESH:D000236 @@@colorectal adenomas@@@ among the 126 @SPECIES_9606 @@@patients@@@ who did not use @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (odds ratio = 0.48, 95% confidence interval = 0.280-0.816, P = 0.008). ", "citations": {"NLM": "Lee JH, Jeon SM, Hong SP, Cheon JH, Kim TI, Kim WH. Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer. Dig Liver Dis. 2012 Dec;44(12):1042-7. PMID: 22789400", "BibTeX": "@article{22789400, title={Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer.}, author={Lee JH and Jeon SM and Hong SP and Cheon JH and Kim TI and Kim WH}, journal={Dig Liver Dis}, volume={44}, number={12}, pages={1042-7}}"}}]}